Key result
Digital cardiac rehabilitation boosts VO2 peak ~1.8 mL/kg/min compared to traditional programs.
Why the study?
While guidelines emphasize transitioning to flexible and remote cardiac rehabilitation models, prior meta-analyses focused heavily on mortality rather than functional outcomes and long-term engagement. Data quantifying the efficacy of Digital Therapeutics on VO2 peak and patient adherence compared to traditional center-based cardiac rehabilitation were needed.
Does digital therapeutics (DTx) improve peak oxygen uptake (VO2 peak) and adherence compared to traditional center-based cardiac rehabilitation in cardiac rehabilitation patients?
Meta-Analysis (n=6,420)
Does digital therapeutics (DTx) improve peak oxygen uptake (VO2 peak) and adherence compared to traditional center-based cardiac rehabilitation in cardiac rehabilitation patients?
Digital therapeutics significantly improve patient adherence and peak oxygen uptake compared to traditional center-based cardiac rehabilitation, supporting the 2026 ESC Guidelines' shift toward hybrid and remote models.
Supports DTx adoption in cardiac rehabilitation; extends meta-analytic evidence for remote models.
Background and Purpose The 2026 ESC Guidelines for Cardiac Rehabilitation emphasize the transition from center-based models to flexible, hybrid, and remote systems to increase accessibility. While prior meta-analyses focused heavily on mortality, "practical education" requires data on functional outcomes and long-term engagement. This study sought to quantify the efficacy of Digital Therapeutics (DTx) on peak oxygen uptake (VO2 peak) and patient adherence compared to traditional center-based cardiac rehabilitation (TCR). Methods We performed a systematic search across PubMed, Embase, Cochrane, and Scopus from inception to January 2026. Randomized controlled trials (RCTs) and high-quality longitudinal studies comparing DTx (smartphone apps, wearables, and remote monitoring) to TCR were included. The primary outcome was change in VO2 peak (mL/kg/min). Secondary outcomes included adherence (percentage of sessions completed). A random-effects model was used for meta-analysis. Meta-regression explored the influence of age, baseline LVEF, and intervention duration. Sensitivity analysis was performed using the "leave-one-out" method and by stratifying for "purely digital" vs. "hybrid" models. Results A total of 42 studies (N=6,420 patients) met the inclusion criteria. * Exercise Capacity: DTx demonstrated non-inferiority to TCR, with a significant Mean Difference (MD) in VO2 peak of +1.82 mL/kg/min (95% CI: 1.24 to 2.40; p < 0.001). * Adherence: Patients in the DTx/Hybrid group showed significantly higher adherence rates compared to TCR (Odds Ratio: 1.45; 95% CI: 1.21 to 1.74; p < 0.01). * Meta-Regression: Age was a significant moderator; younger cohorts (age < 65) showed a greater delta in VO2 peak in digital models, while adherence gains remained consistent across age groups (p = 0.42). * Sensitivity Analysis: Findings remained robust across high-quality RCTs, though heterogeneity (I2 = 54%) was primarily driven by varying levels of human-in-the-loop coaching versus automated feedback. Conclusion In the era of the 2026 ESC Guidelines, Digital Therapeutics are no longer merely "alternative" models; they are superior in facilitating patient adherence and equivalent-if not slightly superior-in improving objective exercise capacity. These findings provide the "practical education" data necessary to validate the widespread implementation of hybrid CR models across Europe.
No takes yet. Share an insight, caveat, or question.
Vijayaraghavan et al. (2026) conducted a meta-analysis in Cardiac rehabilitation candidates (n=6,420). Digital Therapeutics (smartphone apps, wearables, and remote monitoring) vs. Traditional center-based cardiac rehabilitation (TCR) was evaluated on Change in peak oxygen uptake (VO2 peak, mL/kg/min) (MD +1.82 mL/kg/min, 95% CI 1.24 to 2.40, p=< 0.001). Digital therapeutics were non-inferior to traditional cardiac rehabilitation, increasing VO2 peak (MD +1.82 mL/kg/min; 95% CI 1.24-2.40; p<0.001) and adherence (OR 1.45; p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: